Synaptrix
Drug-free pain management solutions for postoperative joint surgery with proprietary electrical stimulation technology.
Date | Investors | Amount | Round |
---|---|---|---|
* | $10.0m | Series A | |
Total Funding | 000k |
Related Content
Synaptrix is a medical device startup focused on the development and commercialization of drug-free pain management solutions specifically designed for patients recovering from postoperative joint surgery. The company's flagship product, the NOVABLOC system, offers a procedure-based solution that utilizes a novel form of electrical stimulation to alleviate pain. This innovative approach has been validated through human feasibility studies, demonstrating the potential to provide up to 20 days of pain relief with a single treatment. Synaptrix primarily serves the healthcare sector, targeting hospitals and clinics that perform joint surgeries. The business model revolves around the sale and distribution of the NOVABLOC system to medical institutions, generating revenue through product sales and potential service agreements. By addressing the need for effective, non-pharmacological pain management, Synaptrix positions itself in a niche market with significant growth potential.
Keywords: medical device, pain management, postoperative, joint surgery, electrical stimulation, drug-free, healthcare, hospitals, clinics, revenue.